
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
Said Jongo, Vicente Urbano, L. W. Preston Church, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 283-293
Open Access | Times Cited: 56
Said Jongo, Vicente Urbano, L. W. Preston Church, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 283-293
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
mRNA vaccine against malaria tailored for liver-resident memory T cells
Mitch Ganley, Lauren E. Holz, Jordan J. Minnell, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1487-1498
Closed Access | Times Cited: 36
Mitch Ganley, Lauren E. Holz, Jordan J. Minnell, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1487-1498
Closed Access | Times Cited: 36
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Immunological factors linked to geographical variation in vaccine responses
Marloes M.A.R. van Dorst, Jeremia J Pyuza, Gyaviira Nkurunungi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 250-263
Closed Access | Times Cited: 29
Marloes M.A.R. van Dorst, Jeremia J Pyuza, Gyaviira Nkurunungi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 250-263
Closed Access | Times Cited: 29
Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27
A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
Debashree Goswami, Hardik Patel, William Betz, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 723-754
Open Access | Times Cited: 15
Debashree Goswami, Hardik Patel, William Betz, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 723-754
Open Access | Times Cited: 15
Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora, Lokhesh C Anbalagan, Ashok Kumar Pannu
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 1033-1039
Open Access | Times Cited: 53
Navneet Arora, Lokhesh C Anbalagan, Ashok Kumar Pannu
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 1033-1039
Open Access | Times Cited: 53
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B. Sirima, Alphonse Ouédraogo, Alfred B. Tiono, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Open Access | Times Cited: 30
Sodiomon B. Sirima, Alphonse Ouédraogo, Alfred B. Tiono, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Open Access | Times Cited: 30
Malaria therapeutics: are we close enough?
Himani Tripathi, Preshita Bhalerao, Sujeet Singh, et al.
Parasites & Vectors (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Himani Tripathi, Preshita Bhalerao, Sujeet Singh, et al.
Parasites & Vectors (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies
Muhammad Chutiyami, Priya Saravanakumar, Umar Muhammad Bello, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2007-2028
Open Access | Times Cited: 6
Muhammad Chutiyami, Priya Saravanakumar, Umar Muhammad Bello, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2007-2028
Open Access | Times Cited: 6
Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity
De Jong, Vincent van Unen, Mikhael D. Manurung, et al.
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 654-665
Open Access | Times Cited: 39
De Jong, Vincent van Unen, Mikhael D. Manurung, et al.
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 654-665
Open Access | Times Cited: 39
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions
Isobel S. Walker, Stephen J. Rogerson
Virulence (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Isobel S. Walker, Stephen J. Rogerson
Virulence (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Five decades of clinical assessment of whole-sporozoite malaria vaccines
Helena Nunes‐Cabaço, Diana Moita, Miguel Prudêncio
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Helena Nunes‐Cabaço, Diana Moita, Miguel Prudêncio
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts
Alex S. Siebner, Marrium Habib, Vanesa Osmani, et al.
Vaccine X (2025), pp. 100615-100615
Open Access
Alex S. Siebner, Marrium Habib, Vanesa Osmani, et al.
Vaccine X (2025), pp. 100615-100615
Open Access
Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
Said Jongo, L. W. Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1215-1226
Open Access | Times Cited: 21
Said Jongo, L. W. Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1215-1226
Open Access | Times Cited: 21
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection
Andrea A. Berry, Thomas L. Richie, L. W. Preston Church, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Andrea A. Berry, Thomas L. Richie, L. W. Preston Church, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Successful insertion and expression of a tetracycline transactivator in Anopheles stephensi associated with increased egg production and decreased hatching rate
Ehud Inbar, Ishaan Samantray, Robert Alford, et al.
(2025)
Closed Access
Ehud Inbar, Ishaan Samantray, Robert Alford, et al.
(2025)
Closed Access
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
Said Jongo, L. W. Preston Church, Florence A. Milando, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 3
Said Jongo, L. W. Preston Church, Florence A. Milando, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 3
Novel malaria vaccines
Matthew B. Laurens
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4549-4552
Open Access | Times Cited: 21
Matthew B. Laurens
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 11, pp. 4549-4552
Open Access | Times Cited: 21
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
Maxmillian Mpina, Thomas C. Stabler, Tobias Schindler, et al.
Malaria Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Maxmillian Mpina, Thomas C. Stabler, Tobias Schindler, et al.
Malaria Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination
Felicia Watson, Melanie J. Shears, Jokichi Matsubara, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1227-1236
Open Access | Times Cited: 14
Felicia Watson, Melanie J. Shears, Jokichi Matsubara, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1227-1236
Open Access | Times Cited: 14
Advancements and Challenges in Developing Malaria Vaccines: Targeting Multiple Stages of the Parasite Life Cycle
Rajneesh, Rahul Tiwari, Vishal Singh, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 10, pp. 1795-1814
Closed Access | Times Cited: 8
Rajneesh, Rahul Tiwari, Vishal Singh, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 10, pp. 1795-1814
Closed Access | Times Cited: 8
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases
José Carlos Solana, Javier Moreno, Salvador Iborra, et al.
Trends in Parasitology (2021) Vol. 38, Iss. 4, pp. 316-334
Open Access | Times Cited: 17
José Carlos Solana, Javier Moreno, Salvador Iborra, et al.
Trends in Parasitology (2021) Vol. 38, Iss. 4, pp. 316-334
Open Access | Times Cited: 17
Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria
Danielle I. Stanisic, Mei‐Fong Ho, Reshma J. Nevagi, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 15
Danielle I. Stanisic, Mei‐Fong Ho, Reshma J. Nevagi, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 15
Plasmodium vivax pre-erythrocytic vaccines
Arturo Reyes‐Sandoval
Parasitology International (2021) Vol. 84, pp. 102411-102411
Open Access | Times Cited: 13
Arturo Reyes‐Sandoval
Parasitology International (2021) Vol. 84, pp. 102411-102411
Open Access | Times Cited: 13